Amazon One Medical Launches GLP-1 Weight Management Program

Amazon One Medical's new weight management program, including access to GLP-1 drugs, marks a significant step in making these popular medications more accessible. Patients can now receive prescriptions with transparent pricing through Amazon Pharmacy, where new GLP-1 pills start at $25 per month with insurance or through cash-pay options as low as $149 per month. This launch comes amid surging demand for GLP-1s, which around 1 in 8 adults are currently taking, according to a poll last year by health policy researcher KFF.

What is Amazon One Medical's GLP-1 Weight Management Program?

GLP-1 receptor agonists, or GLP-1s, mimic the glucagon-like peptide-1 hormone to regulate blood sugar, slow gastric emptying, and reduce appetite, making them highly effective for weight loss and managing chronic conditions like type 2 diabetes and heart disease. Amazon One Medical's program integrates these medications into a holistic weight care approach, overseen by a dedicated primary care provider who monitors progress and adjusts treatment as needed.

The program stands out by combining clinical oversight with convenient fulfillment. Patients can access prescriptions for pill versions of GLP-1s like Wegovy and Foundayo, alongside some injectable medications starting at a cash-pay price of $299 per month. Medications are available for delivery in all 50 states, with same-day delivery in 3,000 cities and towns, and Amazon plans to expand same-day delivery to nearly 4,500 towns by the end of the year.

Eligibility and Getting Started

To participate, patients typically need a consultation with a One Medical provider to assess suitability. Factors like BMI, comorbidities such as diabetes or cardiovascular risks, and medical history determine if GLP-1s are appropriate. Discuss family history of thyroid cancer or pancreatitis with your doctor, as these are contraindications for many GLP-1s. Tools like Shotlee can help track symptoms, side effects, or medication adherence during this process.

Addressing Cost Barriers in GLP-1 Therapy

Despite their effectiveness, GLP-1s remain expensive, with list prices reaching around $1,000 per month. Cost is one of the main reasons patients stop taking GLP-1s, KFF found, even though most people likely need to continue taking the medications to prevent weight regain. Amazon's transparent pricing model tackles this head-on, offering GLP-1 pills at $25/month with insurance or $149 cash-pay, and injectables at $299/month.

This affordability aligns with industry trends. For example, Walmart last week announced it would expand its digital health platform to include weight management care, with the retail giant handling GLP-1 prescription fulfillment. Other retailers, telehealth providers, and pharmaceutical companies have launched similar programs, touting lower prices and support from clinicians and health coaches.

Comparing Amazon's Program to Alternatives

• Amazon One Medical: Dedicated primary care provider, nationwide delivery, same-day options expanding rapidly.
• Walmart: Digital platform focus with in-house fulfillment, but less emphasis on ongoing provider oversight.
• Telehealth Competitors: Often cheaper short-term but may lack integrated pharmacy and primary care continuity.

Amazon argues its program provides a more comprehensive approach, leveraging One Medical's primary care model for sustained support.

GLP-1 Medications: Mechanisms and Broader Benefits

GLP-1s work by activating receptors in the gut and brain, promoting insulin secretion, inhibiting glucagon, and signaling fullness. Beyond weight loss—where patients often see 15-20% body weight reduction—they lower cardiovascular risks and improve glycemic control in diabetes. The KFF poll highlights their popularity, with 1 in 8 adults using them for these purposes.

Common Side Effects and Safety Considerations

While effective, GLP-1s can cause nausea, vomiting, diarrhea, and constipation, especially during initiation. Rare risks include gallbladder issues or pancreatitis. Long-term use requires monitoring for thyroid concerns. Patients should taper doses under medical guidance to minimize rebound weight gain, and regular check-ins via programs like Amazon's ensure safety.

For those with heart disease, GLP-1s offer added value, as select agents like semaglutide (in Wegovy) have shown cardiovascular benefits in trials. Always consult a provider to weigh personal risks versus benefits.

Amazon's Expansion into Healthcare

Amazon has been delving into healthcare for several years. The company acquired primary care chain One Medical for $3.9 billion in 2023, a few years after launching its online pharmacy. In 2024, Amazon folded its telehealth marketplace into One Medical, allowing users to connect to providers through messages or video for a flat fee. Last year, Amazon Pharmacy began rolling out kiosks that dispense common medications at One Medical clinics.

This integration creates a seamless ecosystem: from virtual consults to pharmacy delivery, all under one platform. The GLP-1 program exemplifies how Amazon is positioning itself as a leader in accessible metabolic health care.

Key Takeaways for Patients

• Amazon One Medical's program offers GLP-1s with transparent pricing: $25/month insured pills, $149 cash-pay pills, $299 injectables.
• Dedicated providers oversee care, addressing the need for ongoing use to maintain benefits.
• Nationwide delivery, including same-day in thousands of locations, improves adherence.
• Cost remains a top dropout reason (per KFF), but options like this expand access.
• GLP-1s treat weight, diabetes, and heart disease; discuss with a doctor for personalization.

What This Means for Patients Seeking GLP-1 Therapy

If you're managing obesity, diabetes, or related conditions, Amazon One Medical's program provides a convenient, clinician-supported path to GLP-1s. Start by booking a One Medical visit to evaluate options. Compare with alternatives like Walmart, but prioritize programs with primary care continuity for best outcomes. With high demand and proven efficacy, these initiatives democratize access to transformative therapies.

In summary, this launch preserves the core benefits of GLP-1s while mitigating barriers like cost and logistics, empowering more patients to achieve sustainable health improvements.